A Novel HTNV Budding Inhibitor Interferes the Interaction Between Viral Glycoprotein and Host ESCRT Accessory Protein ALIX
Journal of Medical Virology · 2025-02 · 97 (2)
DOI: 10.1002/jmv.70182 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, online erschienen am 27.01.2025. Verfasst von Qikang Ying und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, School of Basic Medicine, Air Force Military Medical University, Xi'an, China. Hauptthemen laut MEDLINE: Endosomal Sorting Complexes Required for Transport, Virus Release, Antiviral Agents, Glycoproteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: This work was supported by grants from the National Natural Science Fund (No. 82002146, No. 82302525, No. 82272330) and the Shanxi Provincial Project (No. 2021….
Abstract (Originalsprache)
Virus budding is a critical step in the replication cycle of enveloped viruses, closely linked to viral spread, disease progression, and clinical outcomes. The budding of many enveloped RNA viruses is facilitated by the hijacking of the host endosomal sorting complex required for transport (ESCRT) proteins through viral late domains. These late domains are essential for progeny virus production and are highly conserved, making the interaction between late domains and host ESCRT proteins a potential target for the development of antiviral therapeutics. In this study, we elucidated the functional role of the conserved YRTL motif within the glycoprotein Gn cytoplasmic tail of Orthohantavirus hantanense (Hantaan virus, HTNV), demonstrating that HTNV production is regulated by the interaction between YRTL and the ESCRT accessory protein ALIX (ALG‐2 interacting protein X). Through virtual molecule docking screening, followed by in vitro and in vivo assays, we discovered a novel compound, AN‐329, which disrupts the YRTL−ALIX interaction and effectively inhibits infectious HTNV production, as well as Crimean−Congo hemorrhagic fever virus (CCHFV) and Rift Valley fever virus (RVFV) VLP release. This makes AN‐329 a promising therapeutic candidate for reducing viral dissemination. Given that YRTL is conserved across many hantaviruses, our findings may serve as a prototype for the development of broad‐spectrum antiviral drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, School of Basic Medicine, Air Force Military Medical University, Xi'an, China.
- Department of Medicinal Chemistry and Pharmaceutical Analysis, School of Pharmacy, Air Force Military Medical University, Xi'an, China.
- Department of Pathogen Biology, College of Basic Medical Science, Chongqing Medical University, Chongqing, China.
- College of Life Sciences, Yan'an University, Yan'an, China.
ORCID-Profile: Qikang Ying
Förderung
- This work was supported by grants from the National Natural Science Fund (No. 82002146, No. 82302525, No. 82272330) and the Shanxi Provincial Project (No. 2021…
Zitieren
APA
Ying, Q., Zhang, X., Wang, S., Gu, T., Zhang, J., Feng, W., Li, D., Dong, Y., Wu, X., & Wang, F. (2025). A Novel HTNV Budding Inhibitor Interferes the Interaction Between Viral Glycoprotein and Host ESCRT Accessory Protein ALIX. Journal of Medical Virology, 97(2). https://doi.org/10.1002/jmv.70182
Vancouver
Ying Q, Zhang X, Wang S, Gu T, Zhang J, Feng W, et al. A Novel HTNV Budding Inhibitor Interferes the Interaction Between Viral Glycoprotein and Host ESCRT Accessory Protein ALIX. Journal of Medical Virology. 2025;97(2). doi:10.1002/jmv.70182
BibTeX
@article{Ying2025,
author = {Ying, Qikang and Zhang, Xiaoxiao and Wang, Shengzheng and Gu, Tianle and Zhang, Junmei and Feng, Wenjie and Li, Dongjing and Dong, Yuhang and Wu, Xingan and Wang, Fang},
title = {A Novel HTNV Budding Inhibitor Interferes the Interaction Between Viral Glycoprotein and Host ESCRT Accessory Protein ALIX},
journal = {Journal of Medical Virology},
year = {2025},
volume = {97},
number = {2},
doi = {10.1002/jmv.70182}
}
EUVIMED